Literature DB >> 16227325

Convergence of the epidemiology and pathology of COPD.

J Vestbo1, J C Hogg.   

Abstract

The epidemiology of chronic obstructive pulmonary disease (COPD) has been dominated by one hypothesis stating that cigarette smoking and chronic bronchitis were the key to pathogenesis and another that asthma, chronic bronchitis, and even emphysema are related to different expressions of a primary airway abnormality. The first hypothesis was rejected in the late 1960s based on a longitudinal study of working men where only a fraction of smokers developed COPD and where development of COPD was independent of the absence or presence of chronic bronchitis. Chronic bronchitis in more advanced COPD was subsequently associated with a more rapid decline in lung function and more frequent exacerbations. The second hypothesis is more difficult to test but longitudinal studies have shown that the presence of bronchial hyperresponsiveness may predict the subjects who go on to develop COPD. This brief review attempts to reconcile these findings with the pathology found in the lung.

Entities:  

Mesh:

Year:  2005        PMID: 16227325      PMCID: PMC2080699          DOI: 10.1136/thx.2005.046227

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


  40 in total

1.  Hypothesis: does COPD have an autoimmune component?

Authors:  A Agustí; W MacNee; K Donaldson; M Cosio
Journal:  Thorax       Date:  2003-10       Impact factor: 9.139

2.  The relationship between emphysema and chronic bronchitis as assessed morphologically.

Authors:  W M THURLBECK; G E ANGUS
Journal:  Am Rev Respir Dis       Date:  1963-06

Review 3.  Rationale for the Dutch hypothesis. Allergy and airway hyperresponsiveness as genetic factors and their interaction with environment in the development of asthma and COPD.

Authors:  Dirkje S Postma; H Marike Boezen
Journal:  Chest       Date:  2004-08       Impact factor: 9.410

4.  Progress of emphysema in severe alpha 1-antitrypsin deficiency as assessed by annual CT.

Authors:  A Dirksen; M Friis; K P Olesen; L T Skovgaard; K Sørensen
Journal:  Acta Radiol       Date:  1997-09       Impact factor: 1.990

5.  The lung's "quiet zone".

Authors:  J Mead
Journal:  N Engl J Med       Date:  1970-06-04       Impact factor: 91.245

6.  A quantitative study of bronchial mucous gland volume, emphysema and smoking in a necropsy population.

Authors:  R C Ryder; M S Dunnill; J A Anderson
Journal:  J Pathol       Date:  1971-05       Impact factor: 7.996

Review 7.  Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary.

Authors:  R A Pauwels; A S Buist; P M Calverley; C R Jenkins; S S Hurd
Journal:  Am J Respir Crit Care Med       Date:  2001-04       Impact factor: 21.405

8.  Site of airway obstruction in pulmonary disease: direct measurement of intrabronchial pressure.

Authors:  M Yanai; K Sekizawa; T Ohrui; H Sasaki; T Takishima
Journal:  J Appl Physiol (1985)       Date:  1992-03

9.  Methacholine reactivity predicts changes in lung function over time in smokers with early chronic obstructive pulmonary disease. The Lung Health Study Research Group.

Authors:  D P Tashkin; M D Altose; J E Connett; R E Kanner; W W Lee; R A Wise
Journal:  Am J Respir Crit Care Med       Date:  1996-06       Impact factor: 21.405

10.  Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease.

Authors:  G C Donaldson; T A R Seemungal; A Bhowmik; J A Wedzicha
Journal:  Thorax       Date:  2002-10       Impact factor: 9.139

View more
  26 in total

1.  Can early diagnosis and effective management combat the irresistible rise of COPD?

Authors:  Rupert Jones
Journal:  Br J Gen Pract       Date:  2006-09       Impact factor: 5.386

Review 2.  Chronic respiratory disease - the acceptable epidemic?

Authors:  Peter Burney
Journal:  Clin Med (Lond)       Date:  2017-02       Impact factor: 2.659

3.  Activation of the TLR4 signaling pathway and abnormal cholesterol efflux lead to emphysema in ApoE-deficient mice.

Authors:  Monica Goldklang; Polina Golovatch; Tina Zelonina; Jordis Trischler; Daniel Rabinowitz; Vincent Lemaître; Jeanine D'Armiento
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2012-03-23       Impact factor: 5.464

4.  Association of SERPINE2 gene with the risk of chronic obstructive pulmonary disease and spirometric phenotypes in northern Han Chinese population.

Authors:  Li An; Ting Yang; Yongbiao Zhang; Yingxiang Lin; Hong Zhang; Xia Jiao; Lin Hua; Huaping Dai; Chen Wang
Journal:  Mol Biol Rep       Date:  2011-05-25       Impact factor: 2.316

5.  Risk of herpes zoster among patients with chronic obstructive pulmonary disease: a population-based study.

Authors:  Ya-Wen Yang; Yi-Hua Chen; Kuo-Hsien Wang; Chen-Yi Wang; Hui-Wen Lin
Journal:  CMAJ       Date:  2011-02-22       Impact factor: 8.262

6.  Genome-wide study of percent emphysema on computed tomography in the general population. The Multi-Ethnic Study of Atherosclerosis Lung/SNP Health Association Resource Study.

Authors:  Ani Manichaikul; Eric A Hoffman; Joanna Smolonska; Wei Gao; Michael H Cho; Heather Baumhauer; Matthew Budoff; John H M Austin; George R Washko; J Jeffrey Carr; Joel D Kaufman; Tess Pottinger; Charles A Powell; Cisca Wijmenga; Pieter Zanen; Harry J M Groen; Dirkje S Postma; Adam Wanner; Farshid N Rouhani; Mark L Brantly; Rhea Powell; Benjamin M Smith; Dan Rabinowitz; Leslie J Raffel; Karen D Hinckley Stukovsky; James D Crapo; Terri H Beaty; John E Hokanson; Edwin K Silverman; Josée Dupuis; George T O'Connor; H Marike Boezen; Stephen S Rich; R Graham Barr
Journal:  Am J Respir Crit Care Med       Date:  2014-02-15       Impact factor: 21.405

7.  Matrix metalloproteinase-14 mediates a phenotypic shift in the airways to increase mucin production.

Authors:  Hitesh S Deshmukh; Anne McLachlan; Jeffrey J Atkinson; William D Hardie; Thomas R Korfhagen; Maggie Dietsch; Yang Liu; Peter Y P Di; Scott C Wesselkamper; Michael T Borchers; George D Leikauf
Journal:  Am J Respir Crit Care Med       Date:  2009-08-06       Impact factor: 21.405

8.  Heme oxygenase-1 prevents airway mucus hypersecretion induced by cigarette smoke in rodents and humans.

Authors:  Abdelhamid Almolki; Armelle Guenegou; Slawomir Golda; Laurent Boyer; Mourad Benallaoua; Nadia Amara; Rafik Bachoual; Clémence Martin; François Rannou; Sophie Lanone; Jozef Dulak; Pierre-Régis Burgel; Jamel El-Benna; Benedicte Leynaert; A Benedicte Leynaert; Michel Aubier; Jorge Boczkowski
Journal:  Am J Pathol       Date:  2008-09-11       Impact factor: 4.307

9.  Acrolein-activated matrix metalloproteinase 9 contributes to persistent mucin production.

Authors:  Hitesh S Deshmukh; Colleen Shaver; Lisa M Case; Maggie Dietsch; Scott C Wesselkamper; William D Hardie; Thomas R Korfhagen; Massimo Corradi; Jay A Nadel; Michael T Borchers; George D Leikauf
Journal:  Am J Respir Cell Mol Biol       Date:  2007-11-15       Impact factor: 6.914

10.  Absence of association between SERPINE2 genetic polymorphisms and chronic obstructive pulmonary disease in Han Chinese: a case-control cohort study.

Authors:  Li Zhong; Wei-Ping Fu; Chang Sun; Lu-Ming Dai; Ya-Ping Zhang
Journal:  BMC Med Genet       Date:  2009-07-16       Impact factor: 2.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.